Skip to main content
Log in

Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Stress and depression have been linked to relapse of cocaine abuse. Antagonism of the kappa opioid receptor (KOR) has been reported to attenuate some effects of stressors, and antagonism of the KOR has been reported to have antidepressant-like properties.

Objectives

Our objective was to determine whether the potent and selective KOR antagonist, (3R)-7-hydroxy-N-{(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl}-1,2,3,4-tetrahydro-3-isoquinoline-carboxamide (JDTic), can reduce the ability of a stressor (intermittent footshock) to reinstate cocaine-seeking behavior and to have antidepressant-like effects in the forced swim test (FST).

Methods

Male Long–Evans hooded rats were trained to lever-press, reinforced with 0.5 mg/kg i.v. infusion of cocaine, according to fixed ratio 1 reinforcement schedules during daily 2-h experimental sessions. After performance had stabilized, lever pressing was extinguished for 12 consecutive sessions, and doses of 0 (vehicle), 3, 10, and 30 mg/kg JDTic were then administered i.g. to separate groups of 12 rats. Twenty four hours later, the rats were given 15 min of intermittent footshock (0.87 mA, 0.5 s activation time, average interactivation interval of 40 s) or a 17-mg/kg i.p. administration of cocaine prime followed by a 2-h reinstatement test session. JDTic was also evaluated for its ability to block diuresis induced by the KOR agonist, U50,488H (10 mg/kg, s.c.), during 5-h test sessions beginning 1 h after footshock reinstatement tests to verify its KOR antagonist activity. In the FST, male Sprague–Dawley rats were treated with either nor-binaltorphimine (nor-BNI) or JDTic (both at 0.3, 1, 3, or 10 mg/kg, injected s.c. 23 h before), or desipramine (5.6, 10, or 17 mg/kg, injected i.p. 23, 5, and 1 h before) and placed in a cylinder of water, during which the predominance of immobility, swimming, and climbing were scored during 5-s intervals for 5 min.

Results

The 10- and 30-mg/kg doses of JDTic significantly reduced footshock-induced reinstatement of responding previously reinforced by cocaine and significantly attenuated U50,488H-induced diuresis. In contrast, JDTic did not affect cocaine-prime-induced reinstatement. Both nor-BNI and JDTic decreased immobility and increased swimming time in the FST, similar to the antidepressant desipramine.

Conclusions

Depression and stress are two states during cocaine abstinence which users identify as precipitating relapse, and JDTic may have properties which attenuate both.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

JDTic:

(3R)-7-Hydroxy-N-{(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl}-1,2,3,4-tetrahydro-3-isoquinoline-carboxamide

KOR:

kappa opioid receptor

FST:

forced swim test

nor-BNI:

nor-binaltorphimine

References

  • Adamson WT, Windh RT, Blackford S, Kuhn CM (1991) Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo–pituitary–adrenal axis in rats. Endocrinology 129:959–964

    Article  PubMed  CAS  Google Scholar 

  • Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R (1996) The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic–pituitary–adrenal axis: studies in vivo and in vitro. J Neuroendocrinol 8:579–585

    Article  PubMed  CAS  Google Scholar 

  • Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS (2004) Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol 501:111–119

    Article  PubMed  CAS  Google Scholar 

  • Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66–72

    Article  CAS  Google Scholar 

  • Di Chiara G (1995) The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38:95–137

    Article  PubMed  Google Scholar 

  • Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067–1080

    PubMed  Google Scholar 

  • Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry 43:107–113

    PubMed  CAS  Google Scholar 

  • Goeders NE (2002) Stress and cocaine addiction. J Pharmacol Exp Ther 301:785–789

    Article  PubMed  CAS  Google Scholar 

  • Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J (2002) Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry 59:375–380

    Article  PubMed  Google Scholar 

  • Iyengar S, Kim HS, Wood PL (1986) Kappa opiate agonists modulate the hypothalamic–pituitary–adrenocortical axis in the rat. J Pharmacol Exp Ther 238:429–436

    PubMed  CAS  Google Scholar 

  • Katoh A, Nabeshima T, Kameyama T (1990) Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions. J Pharmacol Exp Ther 253:600–607

    PubMed  CAS  Google Scholar 

  • Kelly PH, Iversen SD (1976) Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45–56

    Article  PubMed  CAS  Google Scholar 

  • Kreek MJ (1987) Multiple drug abuse patterns and medical consequences. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 1597–1604

    Google Scholar 

  • Kreek MJ, Koob GF (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51:23–47

    Article  PubMed  CAS  Google Scholar 

  • Leander JD (1983) A kappa opioid effect: increased urination in the rat. J Pharmacol Exp Ther 224:89–94

    PubMed  CAS  Google Scholar 

  • Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, Jones RM, Portoghese PS, Carlezon WA Jr (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323–330

    Article  PubMed  CAS  Google Scholar 

  • Maisonneuve IM, Archer S, Glick SD (1994) U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett 181:57–60

    Article  PubMed  CAS  Google Scholar 

  • McLaughlin JP, Marton-Popovici M, Chavkin C (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23:5674–5683

    PubMed  CAS  Google Scholar 

  • McLaughlin JP, Ippolito D, Pintar JE, Chavkin C (2004) Kappa opioid receptor activation is necessary and sufficient to mediate the stress-induced potentiation of the cocaine CPP response. Society for Neuroscience 34th annual meeting, San Diego, 23–27 October 2004

  • McMahon RC (2001) Personality, stress, and social support in cocaine relapse prediction. J Subst Abuse Treat 21:77–87

    Article  PubMed  CAS  Google Scholar 

  • Menendez L, Andres-Trelles F, Hidalgo A, Baamonde A (1993) Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice. Brain Res 611:264–271

    Article  PubMed  CAS  Google Scholar 

  • Nabeshima T, Katoh A, Wada M, Kameyama T (1992) Stress-induced changes in brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations. Life Sci 51:211–217

    Article  PubMed  CAS  Google Scholar 

  • Newton SS, Thome J, Wallace TL, Shirayama Y, Schlesinger L, Sakai N, Chen J, Neve R, Nestler EJ, Duman RS (2002) Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 22:10883–10890

    PubMed  CAS  Google Scholar 

  • Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr (2001) Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 21:7397–7403

    PubMed  CAS  Google Scholar 

  • Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732

    Article  PubMed  CAS  Google Scholar 

  • Przewlocki R, Lason W, Hollt V, Silberring J, Herz A (1987) The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord. Brain Res 413:213–219

    Article  PubMed  CAS  Google Scholar 

  • Reith ME, Sershen H, Lajtha A (1980) Saturable (3H)cocaine binding in central nervous system of mouse. Life Sci 27:1055–1062

    Article  PubMed  CAS  Google Scholar 

  • Reith ME, Sershen H, Allen DL, Lajtha A (1983) A portion of [3H]cocaine binding in brain is associated with serotonergic neurons. Mol Pharmacol 23:600–666

    PubMed  CAS  Google Scholar 

  • Schenk S, Partridge B (2001) Effect of the kappa-opioid receptor agonist, U69593, on reinstatement of extinguished amphetamine self-administration behavior. Pharmacol Biochem Behav 68:629–634

    Article  PubMed  CAS  Google Scholar 

  • Schenk S, Partridge B, Shippenberg TS (1999) U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology (Berl) 144:339–346

    Article  CAS  Google Scholar 

  • Schenk S, Partridge B, Shippenberg TS (2000) Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593. Psychopharmacology (Berl) 151:85–90

    Article  CAS  Google Scholar 

  • Sershen H, Reith ME, Hashim A, Lajtha A (1984) Reduction of dopamine uptake and cocaine binding in mouse striatum by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur J Pharmacol 102:175–178

    Article  PubMed  CAS  Google Scholar 

  • Shelton KL, Beardsley PM (2005) Interaction of extinguished cocaine-conditioned stimuli and footshock on reinstatement. Int J Comp Psychol 18:154–166

    Google Scholar 

  • Shelton KL, Hendrick E, Beardsley PM (2004) Interaction of noncontingent cocaine and contingent drug-paired stimuli on cocaine reinstatement. Eur J Pharmacol 497:35–40

    Article  PubMed  CAS  Google Scholar 

  • Shirayama Y, Ishida H, Iwata M, Hazama GI, Kawahara R, Duman RS (2004) Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90:1258–1268

    Article  PubMed  CAS  Google Scholar 

  • Sinha R, Fuse T, Aubin LR, O'Malley SS (2000) Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 152:140–148

    Article  CAS  Google Scholar 

  • Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ (2003) Hypothalamic–pituitary–adrenal axis and sympatho–adreno–medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) 170:62–72

    Article  CAS  Google Scholar 

  • Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734–1740

    Article  PubMed  CAS  Google Scholar 

  • Takahashi M, Senda T, Tokuyama S, Kaneto H (1990) Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia. Jpn J Pharmacol 53:487–494

    Article  PubMed  CAS  Google Scholar 

  • Thomas JB, Atkinson RN, Rothman RB, Fix SE, Mascarella SW, Vinson NA, Xu H, Dersch CM, Lu Y, Cantrell BE, Zimmerman DM, Carroll FI (2001) Identification of the first trans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem 44:2687–2690

    Article  PubMed  CAS  Google Scholar 

  • Thomas JB, Atkinson RN, Vinson NA, Catanzaro JL, Perretta CL, Fix SE, Mascarella SW, Rothman RB, Xu H, Dersch CM, Cantrell BE, Zimmerman DM, Carroll FI (2003) Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist. J Med Chem 46:3127–3137

    Article  PubMed  CAS  Google Scholar 

  • Thomas JB, Fix SE, Rothman RB, Mascarella SW, Dersch CM, Cantrell BE, Zimmerman DM, Carroll FI (2004) Importance of phenolic address groups in opioid kappa receptor selective antagonists. J Med Chem 47:1070–1073

    Article  PubMed  CAS  Google Scholar 

  • Werling LL, Frattali A, Portoghese PS, Takemori AE, Cox BM (1988) Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J Pharmacol Exp Ther 246:282–286

    PubMed  CAS  Google Scholar 

  • Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–492

    Article  PubMed  CAS  Google Scholar 

  • You ZB, Herrera-Marschitz M, Terenius L (1999) Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides. J Pharmacol Exp Ther 290:1307–1315

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Reinstatement studies were conducted under support by the National Institute on Drug Abuse contract N01DA-0-8801 to P.M.B. and grant DA09045 to F.I.C. The authors wish to thank Drs. David McCann and Jane Acri of the National Institute on Drug Abuse for their substantive scientific input regarding the execution of these studies. Some of the data contained in this report were presented at the 2005 College on Problems of Drug Dependence Meeting in Orlando, FL.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick M. Beardsley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beardsley, P.M., Howard, J.L., Shelton, K.L. et al. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology 183, 118–126 (2005). https://doi.org/10.1007/s00213-005-0167-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-005-0167-4

Keywords

Navigation